With gene editing tools becoming advanced enough to realise therapeutic potential, decision-makers working in academia and pharma are looking to consolidate their techniques to facilitate disease modelling, drug development and clinical studies.
The NextGen Omics Series US includes...
Over 350 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.
3 outstanding programmes bringing together Europe’s key genomics experts in Next Generation Sequencing, Single Cell Analysis, Genome Editing.
Over 80 case studies, solution & technology presentations and 2 interactive workshops over the 2 days.
Last Year's Agenda at a Glance
FluidFM: a new approach
to CRISPR gene editing
Thursday, Mar 19 2020 | 1:00 PM - 2:00 PM GMT
hosted by Dr. Paul Monnier, Field Application Scientist
& Dr. Maria Milla, Life Sciences Application Scientist